Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.67 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | NAAA | Q02083 | 3/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MLYCD | O95822 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL3219829 | 0.80 | GPR84 (0.52) | GPR84NAAAUSP2L3MBTL1MLYCD | |
| SCHEMBL12999418 | 0.78 | EGLN1 (0.45) | GPR84L3MBTL1 | |
| SCHEMBL29038565 | 0.73 | HDAC3 (0.67) | GPR84PLA2G7NAAADRD2DRD3 | |
| SCHEMBL29038556 | 0.73 | HDAC3 (0.67) | GPR84PLA2G7NAAADRD2DRD3 | |
| SCHEMBL162430 | 0.70 | DRD2 (0.50) | GPR84ALOX15DRD2DRD3MAPT | |
| SCHEMBL10244791 | 0.69 | HDAC3 (0.61) | NAAADRD2DRD3KDM4ETSHR | |
| SCHEMBL4565867 | 0.69 | HDAC3 (0.71) | GPR84PLA2G7ALOX15NAAADRD2 | |
| SCHEMBL19339783 | 0.69 | GPR84 (0.53) | GPR84PLA2G7ALOX15NAAADRD2 | |
| SCHEMBL9979205 | 0.69 | SMN1; SMN2 (0.70) | GPR84NAAAL3MBTL1MLYCDTSHR | |
| SCHEMBL31467551 | 0.68 | EPHX1 (0.64) | NAAAL3MBTL1MLYCDHTTEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10568975-B2 | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof | THE JOHNS HOPKINS UNIVERSITY (US) | 2020-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10568975-B2 | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof | MUC1, DLST, SLC35A1 | GPR84 2531/4885PLA2G7 2773/4885ALOX15 2643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.